Clinical Trial Update: A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib

View source ↗

Summary

This is a completed non-interventional cohort study in adults with NTRK-fusion solid tumors treated with larotrectinib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Vitrakvi (larotrectinib)

Snippet

Sponsor: Centre Leon Berard | Conditions: Solid Tumor, Adult, Locally Advanced Solid Tumor | Status: COMPLETED